Fulcrum Therapeutics, Inc. ($FULC)
Filing Information
| Accession Number | 0001178579-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 15, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
249,946
Total Value
$891,067.48
P&L
+1.5% (+$13,737.04)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Jul 13, 2026 | Purchase | 12,966 | $3.54 | $45,899.64 | 6,676,349 | Indirect | See Footnote | View Details | |
10% Owner | Common Stock | โ | Jul 14, 2026 | Purchase | 53,651 | $3.56 | $190,997.56 | 6,730,000 | Indirect | See Footnote | View Details | |
10% Owner | Common Stock | โ | Jul 14, 2026 | Purchase | 75,952 | $3.58 | $271,908.16 | 6,805,952 | Indirect | See Footnote | View Details | |
10% Owner | Common Stock | โ | Jul 15, 2026 | Purchase | 107,377 | $3.56 | $382,262.12 | 6,913,329 | Indirect | See Footnote | View Details |